IPO: Eris Lifesciences Limited
♦ ISSUE PERIOD : 16th June 2017 to 20th June 2017
♦ PRICE RANGE: Rs 600 to Rs 603
♦ Lot Size: 24 Shares
♦ Issue Size: 28,875,000 Shares
Eris Lifesciences Limited developes, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology;
and anti-infectives. Their focus has been on developing products in the chronic and acute category which are linked to lifestyle related disorders. The chronic category of the IPM contributed 65.6% of their revenues in Fiscal 2017 (Source: IMS TSA MAT, March 2017). Eris Lifesciences Limited were ranked 20th out of 377 domestic and multinational companies present in the chronic category of the IPM, in terms of revenues for Fiscal 2017 (Source: IMS TSA MAT, March 2017). Eris Lifesciences Limited were the fastest growing company, in the chronic category, among the top 25 companies in terms of
revenues, with revenue growth at CAGR of 28.9%, between Fiscals 2013 and 2017 (Source: IMS TSA MAT, March, 2017). Eris Lifesciences Limited generated 34.4% of their revenues from the acute category of the IPM in Fiscal 2017. their revenues from the acute category grew at a CAGR of 12.0% between Fiscals 2013 and 2017 (Source: IMS TSA MAT, March 2017).
Are you fed-up with high brokerage charges??
Invest in IPOs and Stocks at ZERO brokerage!!!
|Issue Period||16-Jun-2017 to 20-Jun-2017|
|Post issue Modification Period||21-Jun-2017 (10.00 A.M. to 1.00 P.M.)|
|Issue Size||Initial Public Offering of up to 28,875,000 Equity Shares (including anchor portion of 12,926,250Equity Shares)|
|Issue Type||100% Book Building|
|Discount||Rs 60 per Equity Share for Eligible Employee category only|
|Price Range||Rs 600 to Rs 603|
|Face Value||Re 1|
|Tick Size||Re 1|
|Bid Lot||24 Equity Shares and in multiples thereof|
|Minimum Order Quantity||24 Equity Shares|
|Maximum Bid Quantity||1,59,48,744 Equity Share|
|Maximum Subscription Amount for Retail Investor||Rs. 2,00,000|
|IPO Market Timings||10.00 a.m. to 5.00 p.m.|
|Book Running Lead Managers||Axis Capital Limited, Citigroup Global Markets India Private Limited and Credit Suisse Securities (India) Private Limited|
|Categories||FI, IC, MF, FII, OTH, CO, IND, NOH and EMP|
|Name of the Registrar||Link Intime India Private Limited|
|Address of the Registrar||C-101, 1st Floor, 247 Park, L.B.S. Marg, Vikhroli (West), Mumbai 400 083, Maharashtra, India|
|Contact person name number and Email id||Ms. Shanti Gopalkrishnan, +91 22 4918 6200, email@example.com|
Stop paying high brokerage!!
Pay ZERO brokerage for IPOs